Financial insights of ICU

MyFinsight

For the quarter ending 2025-09-30, ICU made $183,000 in revenue. -$3,472,000 in net income. Net profit margin of -1897.27%.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Net revenue	183,000	338,000	293,000	22,333.333
Cost of goods sold	14,000	27,000	-	-
Gross profit	169,000	311,000	293,000	22,333.333
Research and development	1,850,000	1,037,000	2,431,000	2,256,333.333
General and administrative	1,898,000	1,030,000	1,684,000	2,228,000
Total operating expenses	3,748,000	2,067,000	4,115,000	4,484,333.333
Loss from operations	-3,579,000	-1,756,000	-3,822,000	-4,462,000
Interest income	107,000	45,000	48,000	14,333.333
Interest expense	0	-	-	-
Other financing costs	0	-	-	-
Interest expense	-	9,000	11,000	-9,333.333
Change in fair value of convertible notes	0	-	-	-
Change in fair value of warrants liability	0	-16,000	-16,000	296,333.333
Other financing costs	-	298,000	-	-
Change in fair value of convertible notes	-	0	-	-1,536,250
Total other income (expense), net	107,000	-246,000	53,000	-2,321,000
Loss before provision for income taxes	-3,472,000	-2,002,000	-3,769,000	-6,783,000
Provision for income taxes	0	0	3,000	750
Net loss	-3,472,000	-2,002,000	-3,772,000	-6,784,000

Earnings per share, diluted	-	-0.18	-0.44	-1.843
Weighted average number of shares outstanding, diluted	-	11,329,517	8,617,932	-114,439
Net loss per share of common stock, basic and diluted (in dollars per share)	-0.13	-0.18	-0.44	-1.843
Weighted-average shares outstanding, basic and diluted (in shares)	26,393,400	11,329,517	8,617,932	-114,439